216 related articles for article (PubMed ID: 27354069)
1. What evidence is there for a delay in diagnostic coding of RA in UK general practice records? An observational study of free text.
Ford E; Carroll J; Smith H; Davies K; Koeling R; Petersen I; Rait G; Cassell J
BMJ Open; 2016 Jun; 6(6):e010393. PubMed ID: 27354069
[TBL] [Abstract][Full Text] [Related]
2. Optimising use of electronic health records to describe the presentation of rheumatoid arthritis in primary care: a strategy for developing code lists.
Nicholson A; Ford E; Davies KA; Smith HE; Rait G; Tate AR; Petersen I; Cassell J
PLoS One; 2013; 8(2):e54878. PubMed ID: 23451024
[TBL] [Abstract][Full Text] [Related]
3. Optimising the use of electronic health records to estimate the incidence of rheumatoid arthritis in primary care: what information is hidden in free text?
Ford E; Nicholson A; Koeling R; Tate A; Carroll J; Axelrod L; Smith HE; Rait G; Davies KA; Petersen I; Williams T; Cassell JA
BMC Med Res Methodol; 2013 Aug; 13():105. PubMed ID: 23964710
[TBL] [Abstract][Full Text] [Related]
4. An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study.
Muller S; Hider SL; Raza K; Stack RJ; Hayward RA; Mallen CD
BMJ Open; 2015 Dec; 5(12):e009309. PubMed ID: 26700281
[TBL] [Abstract][Full Text] [Related]
5. Long-term impact of delay in assessment of patients with early arthritis.
van der Linden MP; le Cessie S; Raza K; van der Woude D; Knevel R; Huizinga TW; van der Helm-van Mil AH
Arthritis Rheum; 2010 Dec; 62(12):3537-46. PubMed ID: 20722031
[TBL] [Abstract][Full Text] [Related]
6. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries.
Kimsey L; Weissman JS; Patel A; Drew A; Koehlmoos T; Sparks JA
Semin Arthritis Rheum; 2019 Apr; 48(5):821-827. PubMed ID: 30190154
[TBL] [Abstract][Full Text] [Related]
7. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.
Edwards CJ; Arden NK; Fisher D; Saperia JC; Reading I; Van Staa TP; Cooper C
Rheumatology (Oxford); 2005 Nov; 44(11):1394-8. PubMed ID: 16030083
[TBL] [Abstract][Full Text] [Related]
8. Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I
Rheumatology (Oxford); 2017 Feb; 56(2):223-230. PubMed ID: 27694337
[TBL] [Abstract][Full Text] [Related]
9. Treatment delays for patients with new-onset rheumatoid arthritis presenting to an Australian early arthritis clinic.
Ison M; Duggan E; Mehdi A; Thomas R; Benham H
Intern Med J; 2018 Dec; 48(12):1498-1504. PubMed ID: 29808525
[TBL] [Abstract][Full Text] [Related]
10. Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal.
Malaviya AN; Gogia SB
Clin Rheumatol; 2016 Sep; 35(9):2163-73. PubMed ID: 27122121
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis referrals and rheumatologist scarcity: a prioritization tool.
Cummins LL; Vangaveti V; Roberts LJ
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):326-31. PubMed ID: 25156328
[TBL] [Abstract][Full Text] [Related]
12. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
Nanji JA; Choi M; Ferrari R; Lyddell C; Russell AS
J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study.
Corominas H; Narváez J; Díaz-Torné C; Salvador G; Gomez-Caballero ME; de la Fuente D; Campoy E; Roig-Vilaseca D; Clavaguera T; Morlà R; Torrente-Segarra V; Arasa X; Gomez-Puerta JA; Möller I; Alegre C; Graell E; Ponce A; Lisbona MP; Pérez-Garcia C; Fíguls R; Sirvent E; Poca V; Sanmartí R
Reumatol Clin; 2016; 12(3):146-50. PubMed ID: 26362843
[TBL] [Abstract][Full Text] [Related]
14. A detailed analysis of treatment delay from the onset of symptoms in early rheumatoid arthritis patients.
De Cock D; Meyfroidt S; Joly J; Van der Elst K; Westhovens R; Verschueren P;
Scand J Rheumatol; 2014; 43(1):1-8. PubMed ID: 24050519
[TBL] [Abstract][Full Text] [Related]
15. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
Kim G; Barner JC; Rascati K; Richards K
Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
[TBL] [Abstract][Full Text] [Related]
16. Delayed diagnosis and treatment of rheumatoid arthritis in Sarawak General Hospital.
Wan SA; Teh CL; Cheong YK; Jobli AT
Med J Malaysia; 2020 Mar; 75(2):141-145. PubMed ID: 32281595
[TBL] [Abstract][Full Text] [Related]
17. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study.
Ng B; Aslam F; Petersen NJ; Yu HJ; Suarez-Almazor ME
Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1490-6. PubMed ID: 22623324
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis.
Jin Y; Desai RJ; Liu J; Choi NK; Kim SC
Arthritis Res Ther; 2017 Jul; 19(1):159. PubMed ID: 28679392
[TBL] [Abstract][Full Text] [Related]
19. Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis.
Zhou SM; Fernandez-Gutierrez F; Kennedy J; Cooksey R; Atkinson M; Denaxas S; Siebert S; Dixon WG; O'Neill TW; Choy E; Sudlow C; ; Brophy S
PLoS One; 2016; 11(5):e0154515. PubMed ID: 27135409
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with use of disease modifying agents for rheumatoid arthritis in the National Hospital and Ambulatory Medical Care Survey.
Gaitonde P; Bozzi LM; Shaya FT
Semin Arthritis Rheum; 2018 Apr; 47(5):649-653. PubMed ID: 29153870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
